The method isolates polyhydroxyalkanoate (PHA) from a PHA-rich bacterial biomass, to the PHA isolated by the method and to a PHA having specific properties. The method treats an aqueous suspension of the PHA-rich bacterial biomass with a minimal amount of sodium hypochlorite, a methanol wash and extraction of PHA from the biomass with dimethyl carbonate (DMC).

The method isolates polyhydroxyalkanoate (PHA) from a PHA-rich bacterial biomass, to the PHA isolated by the method and to a PHA having specific properties. The method treats an aqueous suspension of the PHA-rich bacterial biomass with a minimal amount of sodium hypochlorite, a methanol wash and extraction of PHA from the biomass with dimethyl carbonate (DMC).

Disclosed is a method for preparing a fully-degradable non-woven fabric by spun-bonding, including: (S1) preparation of a poly(caprolactone-co-lactide acid) (P(CL-co-LA)); (S2) preparation of a copolymerized-modified poly(lactide acid) (PLA); and (S3) preparation of a full-degradable non-woven fabric using a spun-bond method. In this disclosure, the PLA is modified in gradient several times to prepare the full-degradable non-woven fabric in combination with an optimized spun-bonding method.

Disclosed is a method for preparing a fully-degradable non-woven fabric by spun-bonding, including: (S1) preparation of a poly(caprolactone-co-lactide acid) (P(CL-co-LA)); (S2) preparation of a copolymerized-modified poly(lactide acid) (PLA); and (S3) preparation of a full-degradable non-woven fabric using a spun-bond method. In this disclosure, the PLA is modified in gradient several times to prepare the full-degradable non-woven fabric in combination with an optimized spun-bonding method.

A method for efficiently producing PHA comprising: inoculating PHA fermentation strains into a fermentation medium for fermentation under the condition of being capable of producing PHA through fermentation; subjecting the fermentation broth to a solid-liquid separation to obtain fermentation supernatant and thallus precipitate; breaking the cell walls of the thallus precipitate, and subjecting the wall-broken products to a plate and frame filtration to prepare PHA; pre-coating a filter cloth for the plate and frame filtration with a PHA layer; at least part of the water of the fermentation medium is PHA process wastewater. The method utilizes the PHA process wastewater as at least part of the water of the fermentation medium, and filters and separates the broken thallus with the plate and frame filtration equipment pre-coated with PHA layer to prepare PHA, thereby recycling the high-salt wastewater, reducing costs, and potentially separating PHA on a large scale for industrial production.

A method for efficiently producing PHA comprising: inoculating PHA fermentation strains into a fermentation medium for fermentation under the condition of being capable of producing PHA through fermentation; subjecting the fermentation broth to a solid-liquid separation to obtain fermentation supernatant and thallus precipitate; breaking the cell walls of the thallus precipitate, and subjecting the wall-broken products to a plate and frame filtration to prepare PHA; pre-coating a filter cloth for the plate and frame filtration with a PHA layer; at least part of the water of the fermentation medium is PHA process wastewater. The method utilizes the PHA process wastewater as at least part of the water of the fermentation medium, and filters and separates the broken thallus with the plate and frame filtration equipment pre-coated with PHA layer to prepare PHA, thereby recycling the high-salt wastewater, reducing costs, and potentially separating PHA on a large scale for industrial production.

A PLG copolymer material, termed a PLG(p) copolymer material, adapted for use in a controlled release formulation for a bioactive material is provided, wherein the formulation exhibits a reduced “initial burst” effect when introduced into the tissue of a patient in need thereof. A method of preparation of the PLG copolymer material is also provided, as are methods of use.

A PLG copolymer material, termed a PLG(p) copolymer material, adapted for use in a controlled release formulation for a bioactive material is provided, wherein the formulation exhibits a reduced “initial burst” effect when introduced into the tissue of a patient in need thereof. A method of preparation of the PLG copolymer material is also provided, as are methods of use.

A process to prepare a (iv) cyclic polyester oligomer composition includes a cyclic polyester oligomer having furanic units and two to five repeat units. The process includes (a) reacting a monomer composition including: (i) a bifunctional furan-derivative and (ii) a diol in an linear oligomerization step to produce a (iii) linear oligomer composition including a linear oligomer species, (b) reacting the (iii) linear oligomer composition in a distillation-assisted cyclization (DA-C) step to form a (iv) cyclic polyester oligomer composition and a (v) diol byproduct. The (v) diol byproduct is removed by evaporation in the distillation-assisted cyclization (DA-C) step.

A process to prepare a (iv) cyclic polyester oligomer composition includes a cyclic polyester oligomer having furanic units and two to five repeat units. The process includes (a) reacting a monomer composition including: (i) a bifunctional furan-derivative and (ii) a diol in an linear oligomerization step to produce a (iii) linear oligomer composition including a linear oligomer species, (b) reacting the (iii) linear oligomer composition in a distillation-assisted cyclization (DA-C) step to form a (iv) cyclic polyester oligomer composition and a (v) diol byproduct. The (v) diol byproduct is removed by evaporation in the distillation-assisted cyclization (DA-C) step.